Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Drews

Showing results (241-250 of 307) with videos related to

Pageof 31
Sort By:
Journal of Applied Physics|October 22, 2014
Sensing glucose concentrations at GHz frequencies with a fully embedded Biomicro-electromechanical system (BioMEMS)M Birkholz, K-E Ehwald, T Basmer, et al.
Plos One|September 23, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standardSahar Saeed, Sheila F O'Brien, Kento Abe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2020
Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With InfluenzaNelson Lee, Stephanie W Smith, David S C Hui, et al.
Journal of Clinical Microbiology|October 23, 2009
Multicenter comparison of two norovirus ORF2-based genotyping protocolsKirsten Mattison, Elsie Grudeski, Brian Auk, et al.
Transfusion|March 24, 2026
Using blood donor surveillance and clinical case data to shape our understanding of Babesia epidemiology in Manitoba, CanadaSteven J Drews, Carmen L Charlton, Sandra Ramirez-Arcos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 3, 2016
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a virusesDanuta M Skowronski, Suzana Sabaiduc, Catharine Chambers, et al.
The Journal of Infectious Diseases|October 14, 2017
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in CanadaDanuta M Skowronski, Catharine Chambers, Suzana Sabaiduc, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2016
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016Catharine Chambers, Danuta M Skowronski, Suzana Sabaiduc, et al.
Access Microbiology|December 11, 2023
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccinationMichael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.
Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Pageof 31

Showing results (241-250 of 307) with videos related to

Sort By:
Pageof 31
Journal of Applied Physics|October 22, 2014
Sensing glucose concentrations at GHz frequencies with a fully embedded Biomicro-electromechanical system (BioMEMS)M Birkholz, K-E Ehwald, T Basmer, et al.
Plos One|September 23, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standardSahar Saeed, Sheila F O'Brien, Kento Abe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2020
Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With InfluenzaNelson Lee, Stephanie W Smith, David S C Hui, et al.
Journal of Clinical Microbiology|October 23, 2009
Multicenter comparison of two norovirus ORF2-based genotyping protocolsKirsten Mattison, Elsie Grudeski, Brian Auk, et al.
Transfusion|March 24, 2026
Using blood donor surveillance and clinical case data to shape our understanding of Babesia epidemiology in Manitoba, CanadaSteven J Drews, Carmen L Charlton, Sandra Ramirez-Arcos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 3, 2016
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a virusesDanuta M Skowronski, Suzana Sabaiduc, Catharine Chambers, et al.
The Journal of Infectious Diseases|October 14, 2017
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in CanadaDanuta M Skowronski, Catharine Chambers, Suzana Sabaiduc, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2016
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016Catharine Chambers, Danuta M Skowronski, Suzana Sabaiduc, et al.
Access Microbiology|December 11, 2023
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccinationMichael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.
Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.
Pageof 31